Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

20%(1 trials)

Phase Distribution

Ph not_applicable

50%

Ph phase_2

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Other(1)

Detailed Status

Completed5

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (25.0%)

N/A3 (75.0%)

Trials by Status

completed583%

unknown117%

Recent Activity

0 active trials

Showing 5 of 6

unknown

MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00902577

completednot_applicable

Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer

NCT01428739

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT05565690

Role of MRS in Brain Lesions

Unknown

NCT04859816Not Applicable

Fat Absorption and Metabolism After Roux-en-Y Gastric Bypass

Completed

NCT02843230

Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI

Completed

NCT00902577Phase 2

MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

Completed

NCT01428739Not Applicable

Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer

Completed

NCT01226589Not Applicable

Pharmacist Discharge Medication Reconciliation Study

Completed

All 6 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 6